Form4insider filings, from the source

SEC Form 4 · accession 0000899243-18-031588

FATE THERAPEUTICS INC · FATE

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner
Amir Nashat
Director
Period of report
Dec 19, 2018
Accepted (ET)
Dec 21, 2018 · 4:12 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001434316

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common StockF1,F2Dec 19, 2018S64,989$13.2078D1,882,881ISee Footnote
Common StockF3,F2Dec 19, 2018S23,023$13.9584D1,859,858ISee Footnote
Common StockF1,F4Dec 19, 2018S1,261$13.2043D1,858,597ISee Footnote
Common StockF5,F4Dec 19, 2018S454$13.9591D1,858,143ISee Footnote
Common StockF1,F6Dec 19, 2018S423$13.1664D1,857,720ISee Footnote
Common StockF3,F6Dec 19, 2018S180$13.9628D1,857,540ISee Footnote
Common StockF1,F7Dec 19, 2018S640$13.1946D1,856,900ISee Footnote
Common StockF3,F7Dec 19, 2018S240$13.9629D1,856,660ISee Footnote

Table II — derivative securities

No Table II lines on this filing.

Explanation of responses